EVOLVE BIOLOGICS
Live / Registered — Registered (as of 23 Mar 2021)
What this means for you
Registered since 23 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87717949
- Registration number
- 6297748
- Mark type
- Word mark
- Filed
- 12 Dec 2017
- Published for opposition
- 05 Jan 2021
- Registered
- 23 Mar 2021
- Attorney of record
- Christopher J. Schulte
Goods and services
- Class 005 — Pharmaceuticals: Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
- Class 037 — Building construction and repair services: Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
- Class 040 — Treatment of materials: Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
- Class 041 — Education and entertainment services: Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
Owner
- EVOLVE BIOLOGICS INC., Mississauga, Ontario, CA
- Therapure Biopharma Inc., Mississauga, Ontario, CA
- Therapure Biopharma Inc., Mississauga, Ontario, CA
Prosecution history
- 23 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jul 2021 — REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
- 07 Jul 2021 — CORRECTION UNDER SECTION 7 - PROCESSED
- 01 Jul 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 19 Apr 2021 — TEAS SECTION 7 REQUEST RECEIVED
- 23 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 05 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jan 2021 — PUBLISHED FOR OPPOSITION
- 16 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Dec 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 26 Nov 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Nov 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Nov 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jul 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED